Gunnar Magnus Modee Persson
Chairman at INITIATOR PHARMA A/S
Net worth: 62 064 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Garry Neil | M | 70 | 4 years | |
| Henrik Kristian Moltke | M | 66 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 8 years |
| Hans Lennart Rudolf Wigzell | M | 86 |
Karolinska Institutet
| 29 years |
| Peter Buhl Jensen | M | 69 |
Medical Prognosis Institute, Inc.
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 16 years |
| Carani Sanjeevi | M | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
Karolinska Institutet
| 28 years |
| Thoas Michael Fioretos | M | 66 | 15 years | |
| Gunilla Anders Ekström | M | 66 |
Karolinska Institutet
| 2 years |
| Carl Johan Bertil Sundberg | M | 66 |
Karolinska Institutet
| 4 years |
| Magnus Nilsson | M | 68 | 9 years | |
| Christopher Sullivan | M | 40 | 6 years | |
| Anki Forsberg | F | - |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 25 years |
| Claus Elsborg Olesen | M | 50 | 8 years | |
| Göran Forsberg | M | 61 | 10 years | |
| Sven Arne Andréasson | M | 72 | 8 years | |
| Lajos Gunnar Németh | M | 72 |
Karolinska Institutet
| 21 years |
| Anna-Karin Edstedt Bonamy | M | 50 |
Karolinska Institutet
| 14 years |
| Peter Sackey | M | 53 |
Karolinska Institutet
| 4 years |
| Theresa Tse | F | 32 | 7 years | |
| Hans Schambye | M | 59 |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | 13 years |
| Ewa Björling | M | 63 |
Karolinska Institutet
| - |
| Patricia Delaite | M | 61 | 7 years | |
| Steen Meier Knudsen | M | 63 |
Medical Prognosis Institute, Inc.
| - |
| Peter Holm | M | 50 | 8 years | |
| Flavia Borellini | M | 65 | 4 years | |
| Ulf Simonsen | M | 61 | 8 years | |
| Annette Colin Lövgren | F | 59 | 3 years | |
| Karin Leandersson | F | 52 | 8 years | |
| Damian Marron | M | 62 | 3 years | |
| Anders Martin-Löf | M | 53 | 6 years | |
| June Almenoff | M | 67 | 3 years | |
| Dino Miano | M | - | - | |
| Mikael Søndergaard Thomsen | M | 56 | 8 years | |
| Lars-Olof Hansson | M | 80 |
Karolinska Institutet
| 30 years |
| Gilla Kaplan | M | 76 | 4 years | |
| Peter Sjöstrand | M | 78 |
Karolinska Institutet
| - |
| Han Jing Xie | M | 54 |
Karolinska Institutet
| 4 years |
| Thomas Perlmann | M | - |
Karolinska Institutet
| - |
| Björn Ingemar Odlander | M | 66 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 28 years |
| Alex Valcu | M | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 20 years |
| Eva Cecila Marlow | F | 64 |
Mordin AB
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden. | - |
| Klas Kärre | M | 70 |
Karolinska Institutet
| - |
| Daniel Joseph Calvo | M | - |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Mitchell Chan | M | 43 | 3 years | |
| Björn Cochlovius | M | 56 | 4 years | |
| Anna Martling | M | 55 |
Karolinska Institutet
| - |
| Hans Andreasson | M | 69 |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Johan Rutger Christenson | M | 65 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.
Karolinska Institutet
| 38 years |
| Christine Lind | F | 50 | 4 years | |
| Lisa Hegg | M | - | - | |
| Jan-Ingmar Flock | M | 75 |
Karolinska Institutet
| - |
| Ronald Li | M | - |
Karolinska Institutet
| 8 years |
| Colleen Matkowski | F | - | - | |
| David Liberg | M | 55 | 9 years | |
| Märta Segerdahl | M | 68 |
Karolinska Institutet
| - |
| Lars Thorsson | M | 63 | 9 years | |
| Anders Gabrielsen | M | 58 |
Karolinska Institutet
| - |
| Gerrit J. C. van den Dool | M | 70 |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Magnus Westgren | M | 73 |
Karolinska Institutet
| 18 years |
| Kenneth R. Chien | M | - |
Karolinska Institutet
| - |
| David J. Parker | M | - |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| David Patteson | M | 69 |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Matti Sällberg | M | 63 |
Karolinska Institutet
| 24 years |
| Anders Vahlne | M | 78 |
Karolinska Institutet
| 30 years |
| Joseph deBethizy | M | 74 |
Albumedix A/S
 Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark. | 8 years |
| Stig Gösta Ollmar | M | 78 |
Karolinska Institutet
| 27 years |
| Rolf Lewensohn | M | - |
Karolinska Institutet
| - |
| Erna Möller | F | - |
Karolinska Institutet
| - |
| Søren Lemonius | M | 59 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Rolf Valter Rikard Kiessling | M | 76 |
Karolinska Institutet
| 30 years |
| Carola Elisabet Lemne | M | 66 |
Karolinska Institutet
| 26 years |
| Dorrit T. Andersen | F | - |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Ola Winqvist | M | 58 |
Karolinska Institutet
| - |
| Torgny H. Svensson | M | - |
Karolinska Institutet
| - |
| Erik Gustav Magnus Axelson | M | - |
Karolinska Institutet
| - |
| Lars Olov Larsson | M | - |
Karolinska Institutet
| - |
| Gunvor Ester Ekman-Ordeberg | M | 80 |
Karolinska Institutet
| 23 years |
| Lennart Hammarstrom | M | - |
Karolinska Institutet
| - |
| John Wahren | M | - |
Karolinska Institutet
| - |
| Ralf Morgenstern | M | 72 |
Karolinska Institutet
| - |
| Søren Møller | M | 56 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Nanna Liebach Lüneborg | M | 49 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Jan Peter Andersson | M | 73 |
Karolinska Institutet
| 14 years |
| Liselotte Larsson | M | 61 | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Simon Pedder | M | 63 | 2 years | |
| Sijme Zeilemaker | M | 37 | 4 years | |
| Blake Paterson | M | 67 | 4 years | |
| Uli Alf Hacksell | M | 74 | 5 years | |
| Michael Cola | M | 64 | 2 years | |
| Jim van Heusden | M | 53 | 2 years | |
| Federica O’Brien | F | 66 | 2 years | |
| Isaac Blech | M | 73 | 8 years | |
| Steven Boyd | M | 43 | 5 years | |
| Frank Knudsen | M | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| Carlos de Sousa | M | 66 | 3 years | |
| James Cullem | M | 56 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 4 years |
| Sol Barer | M | 76 | 1 years | |
| Robert C. Moscato | M | 48 | 1 years | |
| James Harrell | M | 54 | 4 years | |
| Joseph Miller | M | 50 | 4 years | |
| Thomas H. Aasen | M | 63 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 64 | 64.00% |
| United States | 22 | 22.00% |
| Denmark | 17 | 17.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gunnar Magnus Modee Persson
- Personal Network
